Literature DB >> 35598226

Effect of age on primary balloon dacryocystoplasty and probing success in congenital nasolacrimal duct obstruction.

Volkan Dericioğlu1, Mehmet Orkun Sevik1, Sena Sümmen Saçu2, Muhsin Eraslan1, Eren Çerman3.   

Abstract

PURPOSE: To compare the success rates of balloon dacryocystoplasty (BDP) and probing as a primary procedure in congenital nasolacrimal duct obstruction (CNLDO) and investigate the effect of age on both procedures.
METHODS: A total of 135 patients (171 eyes) with simple and incomplete complex CNLDO were included in this retrospective study; complete complex CNLDO cases were excluded. The success rates for primary BDP (118 eyes) and for probing (53 eyes) were compared overall and among the age groups; Group 1 (12-24 months old), Group 2 (25-36 months old), and Group 3 (> 36 months old).
RESULTS: Mean age of the patients was 41.5 ± 27.2 months for primary BDP, and 21.8 ± 10.8 months for probing (p < 0.001). Overall success rates for primary BDP and probing were 81.1% (43/53) and 76.3% (90/118), respectively (p = 0.481). Success rates for BDP and probing among age groups were 93.8% and 85.3% in Group 1 (p = 0.360), 93.3% and 50.0% in Group 2 (p = 0.012), and 63.6% and 27.3% in Group 3 (p = 0.052), respectively. Cox regression analysis showed that the median ages were 18 months for probing and 36 months for primary BDP. The Poisson regression model showed that for every 1-month increase in patients' age, the success rate of probing decreased by 9.7%.
CONCLUSION: Probing success decreased to a point where different treatment options such as primary BDP can be discussed with the patients' parents after 18 months of age. The success of BDP decreased after 36 months, while it maintained a high success rate between 24 and 36 months as primary treatment.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Age; CNLDO; Congenital nasolacrimal duct obstruction; Effect; Primary balloon dacryocystoplasty; Probing

Year:  2022        PMID: 35598226     DOI: 10.1007/s10792-022-02353-y

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.029


  19 in total

1.  Balloon dacryocystoplasty as the primary treatment in older children with congenital nasolacrimal duct obstruction.

Authors:  Po-Liang Chen; Chih-Hsien Hsiao
Journal:  J AAPOS       Date:  2005-12       Impact factor: 1.220

2.  Success of balloon catheter dilatation as a primary or secondary procedure for congenital nasolacrimal duct obstruction.

Authors:  Stanley Tao; Dale R Meyer; John W Simon; Jitka Zobal-Ratner
Journal:  Ophthalmology       Date:  2002-11       Impact factor: 12.079

3.  Balloon catheter dilation for treatment of older children with nasolacrimal duct obstruction.

Authors:  Gregg T Lueder
Journal:  Arch Ophthalmol       Date:  2002-12

4.  Incidence and clinical characteristics of congenital nasolacrimal duct obstruction.

Authors:  Saraniya Sathiamoorthi; Ryan D Frank; Brian G Mohney
Journal:  Br J Ophthalmol       Date:  2018-06-06       Impact factor: 4.638

5.  Spontaneous Resolution and Timing of Intervention in Congenital Nasolacrimal Duct Obstruction.

Authors:  Saraniya Sathiamoorthi; Ryan D Frank; Brian G Mohney
Journal:  JAMA Ophthalmol       Date:  2018-11-01       Impact factor: 7.389

6.  Timing of initial probing and irrigation in congenital nasolacrimal duct obstruction.

Authors:  J A Katowitz; M G Welsh
Journal:  Ophthalmology       Date:  1987-06       Impact factor: 12.079

7.  The rate of symptomatic improvement of congenital nasolacrimal duct obstruction in Japanese infants treated with conservative management during the 1st year of age.

Authors:  Hirohiko Kakizaki; Yasuhiro Takahashi; Shinsuke Kinoshita; Kunihiko Shiraki; Masayoshi Iwaki
Journal:  Clin Ophthalmol       Date:  2008-06

8.  Late and very late initial probing for congenital nasolacrimal duct obstruction: what is the cause of failure?

Authors:  M B Kashkouli; B Beigi; M M Parvaresh; A Kassaee; Z Tabatabaee
Journal:  Br J Ophthalmol       Date:  2003-09       Impact factor: 4.638

Review 9.  Management of congenital nasolacrimal duct obstruction.

Authors:  Yasuhiro Takahashi; Hirohiko Kakizaki; Weng O Chan; Dinesh Selva
Journal:  Acta Ophthalmol       Date:  2009-07-21       Impact factor: 3.761

10.  Success rates of probing for congenital nasolacrimal duct obstruction at various ages.

Authors:  Marta Świerczyńska; Ewelina Tobiczyk; Piotr Rodak; Dorota Barchanowska; Erita Filipek
Journal:  BMC Ophthalmol       Date:  2020-10-08       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.